The regulatory journey for implementation of Integrated Continuous Biomanufacturing for a commercial Enzyme Replacement Therapy product
Conference Dates
October 20 - 24, 2024
Abstract
Please click Additional Files below to see the full abstract.
Recommended Citation
Rebecca Berger, PhD, "The regulatory journey for implementation of Integrated Continuous Biomanufacturing for a commercial Enzyme Replacement Therapy product" in "Integrated Continuous Biomanufacturing VI", Ana Azevedo, Instituto Superior Técnico, Portugal; Aaron Noyes, Apogee Therapeutics, USA; Kevin Brower, Sanofi, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/biomanufact_vi/89
11.pdf (185 kB)
COinS